Corriente Advisors, LLC Lantern Pharma Inc. Call Options Transaction History
Corriente Advisors, LLC
- $9.53 Million
- Q4 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LTRN
# of Institutions
33Shares Held
2.35MCall Options Held
17.1KPut Options Held
1.3K-
Bios Capital Management, LP Fort Worth, TX1.21MShares$6.18 Million5.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.86 Million0.0% of portfolio
-
Cm Management, LLC200KShares$1.02 Million0.77% of portfolio
-
Geode Capital Management, LLC Boston, MA91.9KShares$470,4810.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny88.8KShares$454,6560.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $55.5M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...